Leading Stroke Companies in South Korea | Key Players 2026

Leading Stroke Companies in South Korea

The following is a data-backed list of the leading South Korea Stroke companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Stroke Industry, including Samsung Medical Center, Seoul National University Hospital, and other established names.

List of Stroke companies in South Korea:

1. Samsung Medical Center

A leading tertiary hospital specializing in advanced stroke diagnosis, treatment, rehabilitation, and comprehensive cerebrovascular care programs.

2. Seoul National University Hospital

Provides advanced stroke management services, neurological research, and specialized treatment approaches for cerebrovascular disorders.

3. Asan Medical Center

Offers comprehensive stroke care through specialized neurology departments, emergency interventions, and rehabilitation services.

4. Severance Hospital

Focuses on advanced cerebrovascular treatment, minimally invasive procedures, and multidisciplinary stroke care solutions.

5. Korea University Anam Hospital

Supports stroke prevention, diagnosis, emergency care, and clinical advancements through specialized neurological programs.

6. JW Pharmaceutical

Develops cardiovascular and neurological medicines supporting treatment pathways associated with stroke-related conditions.

7. Hanmi Pharmaceutical

Engages in innovative therapeutic development focused on chronic diseases, including cardiovascular and neurological healthcare areas.

8. Yuhan Corporation

Provides healthcare solutions across multiple therapeutic areas, including medicines supporting vascular and neurological disease management.

9. Daewoong Pharmaceutical

Focuses on pharmaceutical innovation and therapies addressing complex medical conditions, including stroke-associated healthcare needs.

10. Celltrion

Develops advanced biopharmaceutical solutions and expands treatment options across critical healthcare segments.   

Frequently Asked Questions About the Market Study (FAQs):